Popular Posts: 7 Hot Stocks to Buy for High-Momentum Gains7 Companies Warren Buffett Should BuyNow3 Small-Cap Stocks With Sizable Dividends
Forget Snap Inc (SNAP) Stock, Buy Snap-on Incorporated (SNA) Instead Could the New Rite Aid Corporation (RAD) Go Broke? 7 Hot Stocks to Buy for High-Momentum Gains View All Posts
Take the “P” off Snap Inc’s (NYSE:SNAP) stock symbol, and you get Snap-on Incorporated (NYSE:SNA), what I consider the better buy among two beaten-down stocks.
Hot Warren Buffett Stocks To Buy For 2018: Brookline Bancorp Inc.(BRKL)
- [By Dividends4Life]
Memberships and Peers: PBCT is a member of the S&P 500 and a member of the Broad Dividend Achievers Index. The company’s peer group includes: Bank of America Corporation (BAC) with a 0.3% yield, Brookline Bancorp, Inc. (BRKL) with a 3.7% yield and Westfield Financial Inc. (WFD) with a 3.5% yield.
Hot Warren Buffett Stocks To Buy For 2018: Federated Investors, Inc.(FII)
- [By Gregg Greenberg]
Stocks of Federated Investors (FII) fell approximately 9% in 2015, yet Oja expects a big turnaround in 2016, once again due to the prospect of higher rates ahead.
"The money market fund business, which is unprofitable now, should become more profitable as rates rise because Federated has to reimburse for the servicing fees for these funds," said Oja, who also admires the fund company’s 3.5% dividend yield.
Oja added that Federated also has a "good core business of equity and fixed-income asset management."
Hot Warren Buffett Stocks To Buy For 2018: SPDR S&P Biotech ETF (XBI)
- [By ]
Fast forward 12 months and the SPDR S&P Biotech ETF (NYSE:XBI) is higher by almost 50%. But this rally aint over yet. The beginning of 2018 trading is already flashing a new biotech breakout a move that could cement these stocks as some of the years most explosive market leaders.
- [By ]
The SPDR S&P Biotech ETF (NYSE:XBI) and the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) were each approaching important support levels back in mid-November.
- [By ]
After sneaking lower to begin the new trading week, the SPDR S&P Biotech ETF (NYSE:XBI) and the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) were each approaching important support levels.
- [By ]
And while the big drug companies will experience a significant adjustment, biotech companies, with their focus on long term results and outright cures in some cases, are probably poised to perform. The best way to get invested would be with the Biotech Spider ETF (NYSE: XBI).
- [By WWW.KIPLINGER.COM]
Theres been follow-up, too: Valeant Pharmaceuticals Intl Inc (VRX) had to face the Senate in April for aggressively hiking prices on its drugs. Now Mylan NV (MYL) is answering to the government soon after a story showed that EpiPen prices have rocketed 400% since 2008 with no significant improvements to the treatment. This scandal, too, is rocking biotechs including (Link]recommendation SPDR S&P Biotech ETF (XBI).